Bio-Rad Laboratories, Inc. — Company profile
Healthcare · Medical Devices · United States
Last price 379.5 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 10.25B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Details
| Name | Bio-Rad Laboratories, Inc. |
| Sector | Healthcare |
| Industry | Medical Devices |
| Employees | 7450 |
| Founded | 1952 |
| Ceo | Norman Schwartz |
| Country | United States |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US0905721082 |
| Cusip | 090572108 |
| Cik | 0000012208 |
| Sic | 3826 |
| Stock Type | Common Stock |
| Share Class | Class B Shares |
Key executives
| Name | Title |
|---|---|
| Norman D. Schwartz | Chairman and Chief Executive Officer |
| Jonathan P. DiVincenzo | President and Chief Operating Officer |
| Roop K. Lakkaraju CPA | Executive Vice President and Chief Financial Officer |
| James J. Barry | Executive Vice President and President of Life Science Group |
| Rajat Mehta | Executive Vice President of Global Commercial Operations |
| Ruben Argueta | Vice President of Investor Relations |
| Matthew Werner | Senior Vice President and Chief Compliance and Privacy Officer |
| Courtney C. Enloe | Executive Vice President, General Counsel and Secretary |
| Nanditha R. Yelamanchi | Executive Vice President of Global Human Resources |
| Michael Crowley | Executive Vice President of Global Commercial Operations |
Contact
| Address | 1000 Alfred Nobel Drive, Hercules, California 94547, United States |
| Phone | 510 724 7000 |
| Website | https://www.bio-rad.com |